2018. Open-Label Study (ARIDO) Evaluating Long-Term Safety of Topical Glycopyrronium Tosylate (GT) in Patients with Primary Axillary Hyperhydrosis. SKIN The Journal of Cutaneous Medicine. 2, S1 (Feb. 2018), S40. DOI:https://doi.org/10.25251/skin.2.supp.40.